Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James J-H Chong

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Heart, Lung & Circulation|June 5, 2012
Cell therapy for left ventricular dysfunction: an overview for cardiac cliniciansJames J H Chong
Clinical Therapeutics|September 28, 2020
Clarifying the Role of Stem Cells in Cardiac Clinical TherapeuticsJames J H Chong, Peter Thompson
Heart, Lung & Circulation|July 5, 2023
Therapeutic Angiogenesis Using Growth Factors After Myocardial Infarction: From Recombinant Proteins to Gene Therapies and BeyondTejas Deshmukh, James J H Chong
Expert Review of Cardiovascular Therapy|July 1, 2004
Heparin-induced thrombocytopeniaBeng H Chong, James J H Chong
Blood|July 13, 2013
HIT: nucleic acid masquerading as heparinBeng H Chong, James J-H Chong
Biophysical Reviews|July 22, 2020
Growth factor therapy for cardiac repair: an overview of recent advances and future directionsSamuel J White, James J H Chong
Clinical Therapeutics|September 17, 2020
Mesenchymal Stem Cells in Cardiac Repair: Effects on Myocytes, Vasculature, and FibroblastsSamuel J White, James J H Chong
Clinical Therapeutics|October 4, 2020
The Cardiac Injury Immune Response as a Target for Regenerative and Cellular TherapiesRobert D Hume, James J H Chong
Stem Cell Research|August 5, 2014
Cardiac regeneration using pluripotent stem cells--progression to large animal modelsJames J H Chong, Charles E Murry
Blood|March 6, 2010
IVIg immune inhibitory activity: APC is keyBeng H Chong, James J H Chong
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Heart, Lung & Circulation|June 5, 2012
Cell therapy for left ventricular dysfunction: an overview for cardiac cliniciansJames J H Chong
Clinical Therapeutics|September 28, 2020
Clarifying the Role of Stem Cells in Cardiac Clinical TherapeuticsJames J H Chong, Peter Thompson
Heart, Lung & Circulation|July 5, 2023
Therapeutic Angiogenesis Using Growth Factors After Myocardial Infarction: From Recombinant Proteins to Gene Therapies and BeyondTejas Deshmukh, James J H Chong
Expert Review of Cardiovascular Therapy|July 1, 2004
Heparin-induced thrombocytopeniaBeng H Chong, James J H Chong
Blood|July 13, 2013
HIT: nucleic acid masquerading as heparinBeng H Chong, James J-H Chong
Biophysical Reviews|July 22, 2020
Growth factor therapy for cardiac repair: an overview of recent advances and future directionsSamuel J White, James J H Chong
Clinical Therapeutics|September 17, 2020
Mesenchymal Stem Cells in Cardiac Repair: Effects on Myocytes, Vasculature, and FibroblastsSamuel J White, James J H Chong
Clinical Therapeutics|October 4, 2020
The Cardiac Injury Immune Response as a Target for Regenerative and Cellular TherapiesRobert D Hume, James J H Chong
Stem Cell Research|August 5, 2014
Cardiac regeneration using pluripotent stem cells--progression to large animal modelsJames J H Chong, Charles E Murry
Blood|March 6, 2010
IVIg immune inhibitory activity: APC is keyBeng H Chong, James J H Chong
Pageof 8